To evaluate the beneficial and harmful effects of omega-3 polyunsaturated fatty acids supplementation in people with non-alcoholic fatty liver disease.
This is a protocol.
Omega-3 polyunsaturated fatty acids for non-alcoholic fatty liver disease
You may also be interested in:
- Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis
- Weight reduction for non-alcoholic fatty liver disease
- Transient elastography with controlled attenuation parameter (CAP) for diagnosis of moderate or severe steatosis in people with suspected non-alcoholic fatty liver disease
- Lifestyle modifications for non-alcohol related fatty liver disease: a network meta-analysis
- No evidence to support or refute antioxidant supplements for patients with non-alcoholic fatty liver disease and/or steatohepatitis
Health topics: